Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043) | MicrobiomeTrials← Back to trialsNCT07405164
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-03-23Est. Completion: 2034-01-14
Enrollment target: 450 participants Locations- Beth Israel Deaconess Medical Center ( Site 0107), Boston, Massachusetts, United States
- Karmanos Cancer Center ( Site 0108), Detroit, Michigan, United States
- START San Antonio ( Site 0104), San Antonio, Texas, United States
- UZ Leuven ( Site 0900), Leuven, Vlaams-Brabant, Belgium
- Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 1000), Olomouc, Czechia
- Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 1501), Budapest, Hungary
- Rambam Health Care Campus ( Site 1600), Haifa, Israel
- Hadassah Medical Center ( Site 1604), Jerusalem, Israel
- Rabin Medical Center ( Site 1602), Petah Tikva, Israel
- Sourasky Medical Center ( Site 1603), Tel Aviv, Israel
- Isala, locatie Zwolle ( Site 1902), Zwolle, Overijssel, Netherlands
- N.N. Blokhin NMRCO ( Site 2101), Moscow, Moscow, Russia
- Russian Scientific Center of Radiology and Surgical Technologies ( Site 2100), Saint Petersburg, Sankt-Peterburg, Russia
- Samsung Medical Center ( Site 2902), Gangnam, Seoul, South Korea
- Severance Hospital, Yonsei University Health System ( Site 2901), Seodaemun-gu, Seoul, South Korea
Other microbiome trials you might be interested in
Borderline Personality Disorder (BPD)
This study is a mixed-methods, single-arm cross-sectional study comprising 1) a qualitative, exploratory, critical-const…
Heidelberg, GermanyEst. completion Dec 31, 2026
Retinal HemangioblastomaVon Hippel-Lindau Disease
Background:
Retinal hemangioblastoma (RH) is a tumor. It grows from the retina in the eye. It can threaten a person s v…
Bethesda, United StatesCompleted Jun 2, 2026
Asan Medical Center ( Site 2900), Seoul, South KoreaHospital Universitario 12 de Octubre ( Site 2301), Madrid, SpainTaipei Veterans General Hospital ( Site 2800), Taipei, TaiwanME І.І. Mechnykov Dnipro Regional Clinical Hospital ( Site 2601), Dnipropetrovsk, Dnipropetrovsk Oblast, UkraineCNCE Precarpathian Clinical Oncologic Center ( Site 2600), Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine